This is the authors' abstract. We don't add key points for this paper.
Herein, we provide crystallographic and computational evidence that Hashimoto's Rh(2)(S-PTTL)(4) catalyst adopts a "chiral crown" conformation with a reactive chiral face and an unreactive achiral face. In Rh(2)(S-PTTL)(4), all four tert-butyl groups are aligned on the same face of the catalyst, and each C-(t-Bu) bond is roughly parallel to the central Rh-Rh bond. This orients the four phthalimido groups on the opposite face of the catalyst. Also described is an enantioselective and diastereoselective protocol for intermolecular Rh(2)(S-PTTL)(4)-catalyzed cyclopropanation using alpha-alkyl-alpha-diazoesters. Intermolecular cyclopropanation is selective over two competing intramolecular pathways: C-H insertion and beta-hydride elimination. On the basis of density functional theory calculations and the Davies-Singleton model for cyclopropanation, a model for asymmetric induction is proposed.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
DeAngelis et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: